Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study

Ítems similars

• Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
  per: Prins, Martin H, et al.
  Publicat: (2013)
• Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy
  per: Wells, Philip S, et al.
  Publicat: (2014)
• Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
  per: Boonyawat, Kochawan, et al.
  Publicat: (2021)
• Anticoagulation for Patients with Venous Thromboembolism: When is Extended Treatment Required?
  per: Weitz, Jeffrey I., et al.
  Publicat: (2020)
• Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment
  per: Bauersachs, Rupert M, et al.
  Publicat: (2014)